Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
IGHG1		ENSG00000211896	"Immunoglobulin heavy constant gamma 1 (G1m marker)"	P01857	14	105736343-105743071	"Disease related genes, FDA approved drug targets, Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 11451.9;urinary bladder: 3998.0"	"Group enriched"	"Detected in many"	16	"B-cells: 3900.5;Plasma cells: 9883.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"spinal cord: 12.7"	"Immune cell enriched"	"Detected in some"	6	"memory B-cell: 766.8"	"Lineage enriched"	"Detected in many"	123	"B-cells: 766.8"	"Group enriched"	"Detected in many"	9	"Karpas-707: 157.8;U-698: 392.7"									"HPA001245, CAB008642"	Supported				"Immunoglobulin genes"	NA	NA		230000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB008642: AB_1617595, HPA001245: AB_1079121"	"unprognostic (6.47e-3)"	"unprognostic (4.39e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.55e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (3.90e-2)"	"unprognostic (3.25e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.36e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.49e-9)"	"unprognostic (3.12e-1)"	"unprognostic (3.52e-1)"	"unprognostic (8.96e-2)"	"unprognostic (7.61e-2)"	526.0	696.8	0.7	1661.1	0.6	681.1	203.2	0.5	4.5	518.2	2.8	302.1	103.7	210.6	18.4	334.4	661.5	312.9	143.2	0.4	2.2	491.7	356.1	962.4	3281.1	4.7	3.2	407.0	38.5	7.9	35.8	2.3	2.3	209.8	85.1	0.3	391.6	250.8	13.1	28.5	1008.8	27.6	12.7	11451.9	608.9	172.8	1.2	1773.7	1277.9	0.1	5826.8	3998.0	267.2	1.8	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.7	0.0	0.0	2.3	0.0	0.0	0.0	8.4	0.0	5.3	0.0	0.0	0.0	22.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	157.8	0.0	0.0	1.7	2.1	2.6	0.0	0.0	2.9	15.1	3.7	0.0	0.0	18.2	17.0	3.1	0.0	0.0	0.0	0.0	0.2	10.8	0.0	3.2	3.3	4.5	4.9	0.3	392.7	0.1	3.7	0.0	0.2	0.3	0.1	0.3	0.0	0.2	766.8	0.6	0.3	0.4	134.9	0.0	0.1	6.2	0.1	0.1	0.1	0.2	96.2	0.7	0.6	0.5	4.5	0.4	2.2	4.7	3.2	2.3	12.7	1.2	1.8	2.9	73.7	378.5	0.0	3900.5	0.0	8.1	0.0	0.0	0.0	0.5	0.0	2.8	22.8	9.3	0.0	0.0	0.0	0.4	7.0	0.0	0.0	0.5	0.0	0.1	8.5	13.9	83.4	0.0	0.0	0.0	13.6	8.2	0.0	209.4	0.0	46.1	52.9	0.1	0.0	0.0	5.0	0.0	62.8	0.0	0.9	0.0	9.7	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	5.4	0.0	9883.3	9.1	0.0	10.9	1.5	0.1	0.0	0.0	1.5	1.9	1.0	0.0	0.0	0.0	415.6	0.0	13.6	0.1
IGHG2		ENSG00000211893	"Immunoglobulin heavy constant gamma 2 (G2m marker)"	P01859	14	105639559-105644790	"FDA approved drug targets, Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"lymphoid tissue: 4319.4"	"Group enriched"	"Detected in some"	8	"B-cells: 2050.1;Plasma cells: 2918.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	447	"memory B-cell: 339.0;naive B-cell: 119.3"	"Lineage enriched"	"Detected in single"	661	"B-cells: 339.0"	"Group enriched"	"Detected in some"	4	"RH-30: 9.6;RPMI-8226: 25.1"									HPA001245	Approved				"Immunoglobulin genes"	NA	NA		250000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA001245: AB_1079121"	"prognostic favorable (3.53e-4)"	"unprognostic (6.88e-3)"	"unprognostic (2.40e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.40e-2)"	"prognostic favorable (3.30e-6)"	"unprognostic (1.06e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (4.30e-8)"	"unprognostic (4.72e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.40e-2)"	109.5	11.0	1.3	170.0	1.4	34.8	56.0	0.2	4.1	59.9	0.8	202.8	7.5	55.8	0.8	90.2	51.5	20.7	15.2	0.2	1.1	157.5	98.2	171.0	65.4	0.9	0.2	16.3	8.0	0.1	8.2	0.0	0.5	64.2	9.4	0.0	201.2	1.2	3.5	13.3	330.7	1.0	1.5	4319.4	87.2	2.3	0.3	16.7	134.4	0.0	226.0	100.4	104.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	25.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.1	0.0	1.5	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.4	339.0	0.5	0.0	0.3	119.3	0.0	0.0	0.3	0.0	0.0	0.1	0.0	34.5	1.3	1.4	0.2	4.1	0.2	1.1	0.9	0.2	0.5	1.5	0.3	1.8	0.2	54.5	305.3	0.0	2050.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.9	2.8	13.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.2	4.1	0.0	32.5	0.0	0.0	0.0	3.1	0.0	0.0	126.1	0.0	8.2	5.1	0.1	0.0	0.0	0.9	0.0	12.4	0.0	0.2	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	2918.6	0.7	0.0	3.5	0.0	0.0	0.0	0.3	0.9	0.1	0.0	0.0	0.0	0.1	305.5	0.0	0.7	0.0
IGHG3		ENSG00000211897	"Immunoglobulin heavy constant gamma 3 (G3m marker)"		14	105764503-105771405	"Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in many"	7	"lymphoid tissue: 1289.1"	"Group enriched"	"Detected in many"	7	"B-cells: 2548.4;Plasma cells: 4543.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	415	"memory B-cell: 211.0;naive B-cell: 64.4"	"Lineage enriched"	"Detected in single"	636	"B-cells: 211.0"	"Group enriched"	"Detected in some"	5	"HDLM-2: 23.8;Karpas-707: 18.7;U-698: 49.1"														"Immunoglobulin genes"	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (8.49e-3)"	"unprognostic (3.93e-3)"	"unprognostic (1.57e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.71e-2)"	"prognostic favorable (4.00e-5)"	"unprognostic (1.92e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.36e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (8.46e-11)"	"unprognostic (9.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.80e-2)"	"unprognostic (6.79e-2)"	63.6	17.6	0.1	90.8	0.3	65.4	23.8	0.1	1.5	37.9	1.0	30.0	11.6	22.8	0.3	32.2	104.4	8.4	6.7	0.1	0.6	72.8	42.4	194.9	346.3	2.8	0.1	13.4	6.3	0.1	6.8	0.1	0.4	41.4	8.8	0.0	69.9	12.7	1.9	2.3	100.9	1.6	1.2	1289.1	65.4	31.7	0.1	27.1	87.6	0.0	929.0	87.3	29.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	6.0	3.9	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.1	0.0	49.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	211.0	0.0	0.0	0.0	64.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	20.7	0.1	0.3	0.1	1.5	0.1	0.6	2.8	0.1	0.4	1.2	0.1	1.0	1.9	57.7	363.7	0.0	2548.4	0.0	9.7	0.0	0.0	0.0	0.5	0.1	1.9	18.6	11.2	0.0	0.0	0.0	2.0	7.0	0.0	0.0	6.5	0.1	0.2	5.3	13.2	24.5	0.0	0.0	0.0	9.1	2.6	0.0	195.5	0.0	22.9	64.2	0.1	0.0	0.0	7.4	0.0	62.8	0.0	16.4	0.0	7.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.6	0.0	4543.8	13.3	0.0	0.5	2.2	0.0	0.0	0.0	0.7	4.7	0.7	0.0	0.0	0.0	467.3	0.0	13.5	0.1
IGHJ4		ENSG00000240041	"Immunoglobulin heavy joining 4"		14	105864215-105864260	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 416.7;lymphoid tissue: 1568.0;urinary bladder: 551.2"	"Cell type enriched"	"Detected in single"	148	"Plasma cells: 103.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	187	"memory B-cell: 6029.7;naive B-cell: 2618.0"	"Lineage enriched"	"Detected in all"	261	"B-cells: 6029.7"	"Cell line enriched"	"Detected in some"	87	"U-698: 3990.3"															NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"																					0.0	0.0	7.2	0.0	2.9	0.0	240.0	0.9	10.8	0.0	3.6	377.5	0.0	0.0	0.0	200.2	7.4	4.1	12.3	0.9	2.5	0.0	39.1	0.0	0.0	8.9	30.7	0.0	0.0	13.6	0.0	2.5	22.3	7.0	416.7	0.0	0.0	0.0	0.0	20.7	0.0	0.0	2.0	45.4	7.3	3.7	3.1	32.3	3.9	0.0	1568.0	551.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	14.0	17.5	0.0	0.0	0.0	0.0	6.8	3.6	0.0	0.0	0.0	0.0	0.0	8.9	0.0	45.8	0.0	0.0	6.2	0.0	3990.3	0.0	12.2	0.0	13.9	3.6	5.4	5.0	1.3	3.0	6029.7	13.2	4.0	23.1	2618.0	1.5	6.0	20.1	3.3	6.0	0.0	6.6	1048.2	7.2	2.9	0.9	10.8	0.9	2.5	8.9	30.7	22.3	2.0	3.1	1.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	103.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHM		ENSG00000211899	"Immunoglobulin heavy constant mu"	P01871	14	105851705-105856218	"Disease related genes, Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 1315.0;lymphoid tissue: 4112.3"	"Group enriched"	"Detected in many"	14	"B-cells: 3757.1;Plasma cells: 9906.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in all"	16	"memory B-cell: 4278.4;naive B-cell: 6731.2"	"Lineage enriched"	"Detected in all"	19	"B-cells: 6731.2"	"Group enriched"	"Detected in many"	9	"Daudi: 4983.6;U-698: 4905.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			CAB008643	Uncertain				"Immunoglobulin genes"	NA	NA		110000000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB008643: AB_1617732"	"unprognostic (2.91e-3)"	"prognostic favorable (6.49e-4)"	"unprognostic (9.30e-3)"	"unprognostic (9.90e-3)"	"unprognostic (2.05e-1)"	"prognostic favorable (3.70e-6)"	"unprognostic (9.61e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.46e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (5.20e-5)"	"unprognostic (3.01e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.24e-2)"	"unprognostic (6.28e-3)"	52.0	9.0	0.4	373.7	0.4	395.3	56.6	0.2	1.7	67.9	1.8	446.8	1204.9	11.1	10.2	66.8	38.5	141.7	50.5	0.2	0.4	48.4	84.7	180.6	3192.1	1.9	0.3	9.7	44.5	0.6	8.7	3.6	0.7	15.1	201.4	0.0	325.1	6.1	2.7	1.7	1315.0	7.9	1.0	4112.3	528.9	70.9	0.7	117.3	37.0	0.7	497.1	128.0	10.5	0.5	4.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	4983.6	2.9	0.0	0.0	0.8	0.0	0.0	0.0	21.6	0.0	3.0	0.0	0.0	0.0	2.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	1.7	28.7	1.2	0.0	0.0	580.2	2.2	6.9	0.0	0.0	4.0	5.8	3.0	0.5	1.2	0.0	0.2	3.8	6.5	0.0	13.8	1.2	2.5	1.5	1.5	4905.9	0.0	2.4	0.0	10.8	5.4	5.6	3.1	1.2	2.3	4278.4	5.5	6.8	5.4	6731.2	4.5	3.8	25.4	11.4	4.5	346.1	11.4	815.2	0.4	0.4	0.2	1.7	0.2	0.4	1.9	0.3	0.7	1.0	0.7	0.5	1.0	38.5	254.5	0.0	3757.1	0.0	0.2	0.0	1.2	0.0	2.2	0.8	0.3	31.5	14.2	0.0	0.0	0.0	63.8	1.8	0.0	0.0	0.0	0.0	0.1	4.2	6.7	474.1	0.0	0.0	0.0	10.8	27.5	0.0	152.6	0.0	56.7	147.9	0.1	0.0	0.0	2.2	0.0	158.1	0.0	0.0	0.0	12.4	0.0	0.0	5.2	0.0	11.3	0.0	0.0	0.0	1.2	0.0	9906.5	0.3	0.0	2.2	1.5	0.0	0.0	0.4	16.8	0.0	0.0	0.2	0.0	0.0	415.0	0.3	4.1	0.1
IGHV1-18		ENSG00000211945	"Immunoglobulin heavy variable 1-18"	A0A0C4DH31	14	106184901-106185394	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 223.2;lymphoid tissue: 486.7;salivary gland: 234.3"	"Cell type enriched"	"Detected in some"	259	"Plasma cells: 13773.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	21	"memory B-cell: 73.2"	"Lineage enriched"	"Detected in many"	21	"B-cells: 73.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.6;HL-60: 3.0;RPMI-8226: 2.9;TIME: 1.6"														"Immunoglobulin genes"	NA	NA		4700000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (3.47e-4)"	"unprognostic (2.53e-2)"	"unprognostic (8.73e-3)"	"unprognostic (2.56e-2)"	"unprognostic (9.67e-3)"	"prognostic favorable (8.27e-4)"	"unprognostic (5.47e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.50e-2)"	"unprognostic (3.60e-1)"	"unprognostic (4.26e-1)"	"prognostic unfavorable (5.84e-7)"	"unprognostic (3.22e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.44e-2)"	22.0	3.5	0.0	0.0	0.3	0.0	22.9	0.0	0.6	54.6	0.0	223.2	0.0	8.9	4.5	162.5	24.3	7.7	2.3	0.0	0.0	16.2	14.3	58.3	0.0	0.6	0.1	8.5	3.2	1.9	1.3	0.2	0.4	10.8	0.0	0.0	234.3	0.0	0.4	1.3	103.2	2.6	0.0	486.7	84.0	0.5	0.1	0.0	33.9	0.2	0.0	156.1	12.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	3.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.9	0.0	0.0	0.0	0.6	0.5	0.8	0.0	0.0	1.1	1.2	2.9	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.5	0.4	1.0	0.5	0.0	0.3	0.0	1.4	0.0	3.4	0.0	0.1	0.0	0.0	0.1	73.2	0.0	0.0	0.1	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.6	0.1	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	50.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.5	53.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	13773.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	3.2	0.0	0.1	0.0
IGHV1-3	VI-3B	ENSG00000211935	"Immunoglobulin heavy variable 1-3"	A0A0C4DH29	14	106005095-106005574	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 223.2;lymphoid tissue: 629.4"	"Cell type enriched"	"Detected in some"	335	"Plasma cells: 13473.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"memory B-cell: 52.8;naive B-cell: 27.8"	"Lineage enriched"	"Detected in many"	9	"B-cells: 52.8"	"Cell line enriched"	"Detected in some"	11	"Karpas-707: 148.5"														"Immunoglobulin genes"	NA	NA		2600000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.39e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.96e-2)"	"unprognostic (4.93e-2)"		"unprognostic (7.41e-3)"		"unprognostic (2.42e-1)"	"unprognostic (7.85e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (5.67e-7)"	"unprognostic (7.02e-2)"	"unprognostic (4.31e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.26e-1)"	10.6	59.3	0.0	207.8	0.0	36.4	46.7	0.0	0.5	41.6	0.3	193.3	218.5	4.8	15.3	45.5	6.5	85.4	3.2	0.0	0.1	8.2	8.9	40.9	171.8	0.2	0.0	8.4	7.0	0.3	0.6	0.1	0.1	6.0	223.2	0.0	120.6	23.5	0.6	0.9	140.9	11.2	0.0	246.6	189.1	0.4	0.1	57.8	24.2	0.0	629.4	92.1	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	14.1	1.0	148.5	0.0	0.0	0.8	1.1	0.1	0.0	0.0	0.0	0.7	0.7	0.0	0.0	10.0	8.9	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.7	0.0	2.8	1.4	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	52.8	0.6	0.2	0.0	27.8	1.6	0.5	0.0	0.0	0.0	5.8	1.7	6.1	0.0	0.0	0.0	0.5	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	40.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	27.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13473.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	4.5	0.0	0.0	0.0
IGHV1-46		ENSG00000211962	"Immunoglobulin heavy variable 1-46"	P01743	14	106511117-106511856	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 67.9;lymphoid tissue: 125.7;salivary gland: 67.4"	"Cell type enriched"	"Detected in some"	201	"Plasma cells: 8432.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.7;RPMI-8226: 1.2;SH-SY5Y: 1.2;TIME: 2.3;U-266/70: 1.1;U-266/84: 1.2"														"Immunoglobulin genes"	NA	NA		2900000000	"Cluster 24: B-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (6.28e-4)"	"unprognostic (2.49e-2)"	"prognostic favorable (7.34e-4)"	"unprognostic (1.10e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.80e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.76e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.27e-1)"	"prognostic unfavorable (1.56e-6)"	"unprognostic (6.19e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.13e-1)"	5.1	1.3	0.0	0.0	0.0	0.0	7.2	0.0	0.1	6.2	0.0	67.9	0.0	2.5	1.0	4.9	3.5	0.7	5.0	0.0	0.0	3.2	4.2	15.3	0.0	0.1	0.0	3.0	5.3	0.1	0.3	0.3	0.1	1.9	45.1	0.0	67.4	0.0	0.1	0.7	34.2	0.0	0.0	125.7	25.1	0.2	0.0	0.0	10.5	0.2	0.0	5.1	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.3	1.2	0.0	0.0	0.5	1.2	0.2	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.3	0.0	0.1	1.1	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.7	0.0	0.0	0.0	1.9	41.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8432.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0
IGHV2-5		ENSG00000211937	"Immunoglobulin heavy variable 2-5"	P01817	14	106037902-106038365	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 465.8;lymphoid tissue: 1426.6;stomach 1: 707.9"	"Cell type enriched"	"Detected in some"	333	"Plasma cells: 9414.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"memory B-cell: 66.7;naive B-cell: 67.3"	"Lineage enriched"	"Detected in many"	22	"B-cells: 67.3"	"Cell line enriched"	"Detected in some"	5	"Karpas-707: 8.8"														"Immunoglobulin genes"	NA	NA		700000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.38e-2)"	"unprognostic (4.10e-3)"	"unprognostic (2.51e-2)"	"unprognostic (6.62e-3)"		"prognostic favorable (1.41e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.45e-2)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (2.09e-6)"	"unprognostic (2.74e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.56e-1)"	16.9	5.0	0.0	183.0	0.2	112.8	106.0	0.0	0.5	45.0	0.2	465.8	266.6	7.5	2.5	27.9	10.7	65.0	5.8	0.0	0.1	20.9	16.4	83.9	188.0	0.5	0.2	13.8	9.3	1.0	1.1	0.3	0.7	9.4	296.3	0.0	201.4	8.8	0.4	2.9	177.0	17.4	0.3	351.0	707.9	2.3	0.0	121.5	27.6	0.0	1426.6	249.3	12.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	8.8	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.2	1.6	0.4	0.0	0.1	1.2	1.8	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.4	0.6	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	66.7	0.0	0.0	0.1	67.3	0.1	0.1	3.0	0.0	0.0	0.0	0.0	10.5	0.0	0.2	0.0	0.5	0.0	0.1	0.5	0.2	0.7	0.3	0.0	0.4	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.1	27.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	3.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9414.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.0
IGHV3-15		ENSG00000211943	"Immunoglobulin heavy variable 3-15"	A0A0B4J1V0	14	106153624-106154163	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 183.3;lymphoid tissue: 380.2;salivary gland: 177.7;stomach 1: 112.8;urinary bladder: 172.6"	"Cell type enriched"	"Detected in some"	112	"Plasma cells: 6281.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	9	"MAIT T-cell: 21.6;memory B-cell: 24.4"	"Group enriched"	"Detected in many"	9	"B-cells: 24.4;T-cells: 21.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;Daudi: 1.9;HL-60: 2.1;K-562: 2.0;NB-4: 2.4;RH-30: 1.9;RPMI-8226: 4.1;SH-SY5Y: 3.7"														"Immunoglobulin genes"	NA	NA		20000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (8.85e-5)"	"unprognostic (2.07e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.62e-2)"	"prognostic favorable (3.34e-5)"	"unprognostic (5.20e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.67e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (6.85e-2)"	"unprognostic (6.92e-2)"	"unprognostic (7.12e-2)"	"unprognostic (3.63e-1)"	12.2	36.8	0.0	24.7	0.5	1.8	23.2	0.0	1.2	13.0	0.1	183.3	4.5	5.0	0.9	11.7	16.3	29.6	1.4	0.0	0.2	9.1	10.6	40.0	0.0	1.0	0.0	5.8	19.1	0.4	1.3	0.4	0.3	9.5	14.6	0.0	177.7	23.0	0.8	4.2	107.2	0.3	0.0	380.2	112.8	0.5	0.0	0.0	14.9	0.0	10.4	172.6	9.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.8	2.4	0.7	0.0	0.0	0.0	1.9	4.1	0.0	0.0	0.0	3.7	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.6	0.1	0.4	1.6	0.0	0.2	0.0	0.3	0.0	0.2	0.2	0.1	0.1	0.0	21.6	24.4	0.1	0.2	0.2	0.0	0.2	0.1	2.5	0.0	0.0	0.2	0.1	1.8	0.0	0.5	0.0	1.2	0.0	0.2	1.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	56.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	1.1	8.2	0.0	0.0	0.1	1.1	0.6	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6281.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.0
IGHV3-23		ENSG00000211949	"Immunoglobulin heavy variable 3-23"	P01764	14	106268606-106269140	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1683.1;lymphoid tissue: 2989.8"	"Cell type enriched"	"Detected in some"	139	"Plasma cells: 15979.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	406	"memory B-cell: 548.5;naive B-cell: 336.7"	"Lineage enriched"	"Detected in many"	503	"B-cells: 548.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.4;HL-60: 3.3;NB-4: 4.1;RH-30: 3.0;RPMI-8226: 9.0;SH-SY5Y: 5.8"														"Immunoglobulin genes"	NA	NA		42000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.17e-3)"	"unprognostic (5.43e-2)"	"unprognostic (9.68e-3)"	"unprognostic (3.31e-3)"	"unprognostic (1.34e-2)"	"prognostic favorable (3.85e-4)"	"unprognostic (3.26e-1)"	"unprognostic (4.79e-1)"	"unprognostic (7.26e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.79e-7)"	"unprognostic (6.22e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.42e-2)"	66.5	189.3	0.4	912.2	0.4	185.5	343.1	0.1	2.1	80.1	1.5	1683.1	1640.8	37.0	9.8	342.6	30.1	231.2	46.4	0.1	0.3	27.3	56.4	248.7	859.5	0.8	0.1	42.6	31.0	1.5	2.7	0.9	0.4	35.3	1087.1	0.1	697.8	53.4	0.9	15.0	886.8	40.0	0.8	802.7	1058.8	35.0	0.2	197.5	52.3	0.1	2989.8	993.6	27.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.2	4.1	0.7	0.0	0.0	0.6	3.0	9.0	0.0	0.0	2.7	5.8	0.8	0.1	0.0	0.0	0.0	0.0	1.8	0.0	1.3	1.3	1.1	1.5	0.0	0.3	0.0	0.9	0.0	0.4	0.4	0.1	0.2	0.0	0.1	548.5	0.2	0.3	0.3	336.7	0.1	0.2	1.0	0.2	0.2	0.2	0.8	62.4	0.4	0.4	0.1	2.1	0.1	0.3	0.8	0.1	0.4	0.8	0.2	1.4	0.1	0.0	0.0	0.0	114.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	12.0	0.0	0.0	0.0	1.6	19.4	0.0	1.3	0.0	1.8	2.0	0.2	0.0	0.0	0.1	0.0	4.1	0.0	0.0	0.0	3.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15979.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.1	0.0
IGHV3-33		ENSG00000211955	"Immunoglobulin heavy variable 3-33"	P01772	14	106359793-106360324	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1066.7;lymphoid tissue: 2371.2;stomach 1: 1778.8"	"Cell type enriched"	"Detected in some"	26	"Plasma cells: 556.5"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in some"		"cerebral cortex: 4.0"	"Group enriched"	"Detected in many"	101	"memory B-cell: 378.9;naive B-cell: 364.1"	"Lineage enriched"	"Detected in many"	103	"B-cells: 378.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.4;HL-60: 5.3;RPMI-8226: 7.7;SH-SY5Y: 3.8;U-266/70: 8.1"														"Immunoglobulin genes"	NA	NA		7500000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.04e-3)"	"unprognostic (2.38e-2)"	"unprognostic (8.95e-3)"	"prognostic favorable (6.36e-4)"	"unprognostic (6.84e-2)"	"prognostic favorable (7.19e-5)"	"unprognostic (1.80e-1)"	"unprognostic (1.95e-1)"	"unprognostic (7.31e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.18e-1)"	"prognostic unfavorable (4.10e-6)"	"unprognostic (6.23e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.26e-1)"	"unprognostic (5.92e-2)"	27.9	67.4	1.0	513.8	0.8	117.8	289.5	0.2	4.0	53.6	2.4	1066.7	882.1	16.2	14.5	127.5	18.9	141.9	32.9	0.2	0.4	15.7	41.8	210.1	795.2	1.4	0.2	110.0	29.4	1.9	1.7	0.8	0.4	23.2	775.6	0.0	619.6	39.5	0.5	3.6	343.9	37.3	0.5	476.1	1778.8	29.4	0.7	296.8	42.2	0.1	2371.2	379.8	18.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	5.4	0.0	0.5	0.0	0.0	0.0	5.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.1	0.8	0.0	0.0	0.5	0.2	0.3	0.0	0.0	0.8	2.9	7.7	0.0	0.0	1.4	3.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.3	0.7	8.1	0.0	0.2	0.0	0.8	0.0	0.2	0.6	0.1	1.1	0.0	1.9	378.9	3.6	0.9	0.3	364.1	1.4	0.6	1.0	0.2	0.1	0.2	0.5	44.6	1.0	0.8	0.2	4.0	0.2	0.4	1.4	0.2	0.4	0.5	0.7	0.7	0.0	0.0	0.6	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	10.0	2.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	556.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0
IGHV3-43		ENSG00000232216	"Immunoglobulin heavy variable 3-43"	A0A0B4J1X8	14	106470264-106470800	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 211.9;stomach 1: 312.2;urinary bladder: 153.0"	"Cell type enriched"	"Detected in some"	28	"Plasma cells: 557.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	321	"memory B-cell: 29.4;naive B-cell: 39.0"	"Lineage enriched"	"Detected in single"	366	"B-cells: 39.0"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 1.8;SH-SY5Y: 2.3"														"Immunoglobulin genes"	NA	NA		4000000000	"Cluster 24: B-cells - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (2.31e-4)"	"unprognostic (2.22e-2)"	"prognostic favorable (1.46e-4)"	"unprognostic (4.87e-3)"		"prognostic favorable (8.20e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.63e-1)"	"unprognostic (7.27e-3)"	"unprognostic (4.50e-2)"	"unprognostic (8.73e-2)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (1.60e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.75e-2)"	9.3	2.3	0.0	23.7	0.3	11.5	43.7	0.0	0.3	46.0	0.0	101.8	102.5	2.0	0.0	10.2	3.5	10.7	0.4	0.0	0.0	2.7	9.8	10.8	4.3	0.7	0.0	4.2	2.2	1.0	0.3	0.1	0.2	2.7	66.1	0.0	58.1	5.4	0.1	1.0	48.3	4.4	0.0	83.7	312.2	0.2	0.1	0.0	3.8	0.0	211.9	153.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.5	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	29.4	0.0	0.0	0.0	39.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.3	0.0	0.3	0.0	0.0	0.7	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	557.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0
IGHV3-48		ENSG00000211964	"Immunoglobulin heavy variable 3-48"	P01763	14	106537810-106538344	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 516.4;lymphoid tissue: 858.8;stomach 1: 404.9"	"Cell type enriched"	"Detected in some"	100	"Plasma cells: 5878.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Group enriched"	"Detected in some"	527	"memory B-cell: 187.1;naive B-cell: 97.5"	"Lineage enriched"	"Detected in single"	693	"B-cells: 187.1"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.5;SH-SY5Y: 1.6"														"Immunoglobulin genes"	NA	NA		49000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (9.19e-3)"	"unprognostic (1.87e-2)"	"unprognostic (5.12e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.77e-1)"	"prognostic favorable (1.56e-5)"	"unprognostic (1.23e-1)"	"unprognostic (9.59e-2)"	"unprognostic (2.65e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.44e-1)"	"prognostic unfavorable (4.88e-8)"	"unprognostic (1.89e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.15e-1)"	8.7	22.9	0.0	232.6	0.0	81.2	56.4	0.0	1.3	25.9	0.2	434.1	516.4	8.1	0.1	33.4	12.1	38.6	6.9	0.0	0.0	10.8	18.6	32.3	125.3	0.3	0.0	12.2	8.8	0.9	0.9	0.1	0.7	6.8	253.2	0.0	164.6	16.0	0.6	1.6	134.4	17.7	0.1	271.1	404.9	27.9	0.0	36.3	16.0	0.0	858.8	248.6	7.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.9	0.4	0.0	0.0	0.0	0.8	0.9	0.0	0.0	1.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	187.1	0.0	0.0	0.1	97.5	0.0	0.1	0.1	0.0	0.0	0.0	0.2	22.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	58.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.7	17.9	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5878.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0
IGHV3-7		ENSG00000211938	"Immunoglobulin heavy variable 3-7"	P01780	14	106062151-106062683	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 461.3;lymphoid tissue: 971.3"	"Cell type enriched"	"Detected in some"	255	"Plasma cells: 20463.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 18.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	147	"memory B-cell: 134.0;naive B-cell: 107.0"	"Lineage enriched"	"Detected in single"	163	"B-cells: 134.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.6;HL-60: 3.1;K-562: 3.0;NB-4: 3.0;RPMI-8226: 5.8;SH-SY5Y: 4.8;TIME: 2.9"														"Immunoglobulin genes"	NA	NA		39000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.29e-2)"	"unprognostic (5.57e-3)"	"unprognostic (1.37e-2)"			"prognostic favorable (1.47e-6)"	"unprognostic (1.00e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (4.35e-5)"	"unprognostic (5.18e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.70e-2)"	47.8	10.1	0.7	50.1	1.0	71.1	202.7	0.3	0.8	87.4	0.6	461.3	154.1	37.7	8.2	17.8	13.4	37.0	2.2	0.2	0.4	17.6	20.3	56.4	102.5	1.6	2.8	24.7	4.8	2.9	1.8	0.3	2.3	9.2	303.5	0.0	265.5	22.9	1.3	9.6	206.0	3.6	3.9	610.4	230.4	13.2	0.4	0.0	21.1	0.1	971.3	42.9	14.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	3.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.0	0.0	0.0	0.0	0.0	3.0	0.5	0.0	0.0	0.4	2.6	5.8	0.0	0.0	2.3	4.8	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.7	0.0	1.2	1.6	0.0	0.1	0.0	0.6	0.0	0.4	0.8	0.2	0.1	0.0	0.2	134.0	0.2	0.2	0.3	107.0	0.1	0.1	0.1	0.1	0.2	0.6	0.2	12.6	0.7	1.0	0.3	0.8	0.2	0.4	1.6	2.8	2.3	3.9	0.4	1.3	0.0	0.0	0.0	0.0	80.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	30.5	0.0	5.3	0.0	0.0	0.0	4.4	31.1	0.0	0.0	0.0	2.2	1.9	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20463.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.0	0.0	0.0	7.4	0.0	0.5	0.0
IGHV4-34		ENSG00000211956	"Immunoglobulin heavy variable 4-34"	P06331	14	106373663-106374145	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 283.3;urinary bladder: 278.5"	"Cell type enriched"	"Detected in some"	197	"Plasma cells: 15696.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	602	"U-698: 5353.4"														"Immunoglobulin genes"	NA	NA		4300000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (5.34e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.34e-3)"	"unprognostic (6.12e-2)"	"prognostic favorable (2.77e-4)"	"unprognostic (8.06e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.27e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (2.55e-6)"	"unprognostic (2.61e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.75e-1)"	"unprognostic (7.51e-2)"	7.9	3.0	0.0	0.0	0.3	0.0	9.8	0.1	1.5	12.0	0.1	83.5	0.0	5.5	0.9	7.3	22.5	0.0	2.3	0.0	0.2	7.2	7.0	33.4	0.0	0.6	0.2	22.0	1.3	0.4	0.9	0.3	0.3	3.8	2.2	0.0	82.1	0.0	0.3	2.8	54.2	0.3	0.1	283.3	48.0	0.3	0.1	0.0	19.3	0.0	0.0	278.5	4.0	1.4	3.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.5	2.6	3.2	0.0	0.0	1.4	0.0	4.1	0.0	0.3	0.0	0.6	3.7	0.0	0.1	8.8	0.4	1.8	0.0	0.8	5353.4	0.0	3.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.1	0.5	0.0	0.8	0.0	0.3	0.1	1.5	0.0	0.2	0.6	0.2	0.3	0.1	0.1	1.4	0.0	0.0	0.0	0.0	79.4	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	53.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15696.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	5.6	0.0	0.0	0.0
IGHV4-39		ENSG00000211959	"Immunoglobulin heavy variable 4-39"	P01824	14	106421711-106422218	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 251.6;lymphoid tissue: 474.9;salivary gland: 247.1;urinary bladder: 541.3"	"Cell type enriched"	"Detected in some"	432	"Plasma cells: 48104.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.6;naive B-cell: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.3;Daudi: 1.8;HL-60: 2.4;NB-4: 2.2;RH-30: 2.1;RPMI-8226: 1.4;U-266/70: 2.1;U-698: 2.0"														"Immunoglobulin genes"	NA	NA		5000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.18e-3)"	"unprognostic (2.99e-3)"	"unprognostic (5.95e-3)"	"unprognostic (1.46e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (2.60e-6)"	"unprognostic (2.04e-2)"	"unprognostic (2.77e-1)"	"unprognostic (7.68e-2)"	"unprognostic (8.33e-2)"	17.8	6.5	0.5	378.0	0.5	14.5	33.2	0.1	0.8	24.0	1.5	251.6	4.4	12.5	2.5	19.1	17.7	0.0	11.4	0.1	0.2	13.8	13.8	54.9	0.0	0.8	1.2	17.6	3.7	1.2	1.4	0.0	0.6	7.1	5.0	0.0	247.1	9.5	0.5	12.1	143.6	2.0	0.1	474.9	108.1	1.3	0.4	2.8	37.2	0.0	5.3	541.3	13.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	1.1	2.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.6	0.0	0.2	0.2	0.0	2.1	0.0	2.0	0.0	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.2	1.6	0.1	0.1	0.1	1.7	0.5	0.1	1.1	0.1	0.1	0.2	0.1	0.0	0.5	0.5	0.1	0.8	0.1	0.2	0.8	1.2	0.6	0.1	0.4	0.3	0.0	0.0	0.0	0.0	89.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	111.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48104.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.3	0.0	0.3	0.0
IGHV4-59		ENSG00000224373	"Immunoglobulin heavy variable 4-59"	P01825	14	106627249-106627825	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 525.9;lymphoid tissue: 911.2;urinary bladder: 702.5"	"Cell type enriched"	"Detected in some"	301	"Plasma cells: 12374.9"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in some"		"spinal cord: 2.0"	"Group enriched"	"Detected in some"	37	"memory B-cell: 169.0;naive B-cell: 77.2"	"Lineage enriched"	"Detected in many"	51	"B-cells: 169.0"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 8.1;SCLC-21H: 2.0;SH-SY5Y: 4.2"														"Immunoglobulin genes"	NA	NA		5500000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (1.62e-5)"	"unprognostic (3.95e-2)"	"unprognostic (7.25e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.13e-2)"	"prognostic favorable (9.18e-5)"	"unprognostic (2.88e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.68e-1)"	"prognostic unfavorable (1.41e-7)"	"unprognostic (6.04e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.76e-1)"	23.9	3.2	0.0	260.5	0.3	95.5	89.3	0.0	1.1	40.4	0.8	525.9	301.0	12.1	2.7	89.6	17.9	168.0	27.9	0.0	0.6	13.8	20.6	89.9	148.0	0.3	0.1	23.5	10.3	1.7	1.5	0.3	0.2	12.6	456.0	0.0	225.7	8.8	0.5	3.6	222.6	19.5	2.0	465.3	260.5	15.0	0.2	86.4	44.1	0.0	911.2	702.5	10.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	1.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.8	0.0	0.0	0.0	8.1	1.0	0.3	0.3	0.0	0.8	1.0	0.7	0.0	0.0	2.0	4.2	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.4	0.4	0.1	1.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	169.0	0.0	0.2	1.4	77.2	0.1	0.0	0.0	0.0	0.1	3.3	0.1	11.9	0.0	0.3	0.0	1.1	0.0	0.6	0.3	0.1	0.2	2.0	0.2	0.3	0.0	0.0	0.6	0.0	41.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	11.2	0.0	0.0	0.0	0.7	1.2	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12374.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	3.6	0.0	0.5	0.0
IGHV5-51		ENSG00000211966	"Immunoglobulin heavy variable 5-51"	A0A0C4DH38	14	106578744-106579236	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 245.7;lymphoid tissue: 547.1;salivary gland: 224.5;urinary bladder: 353.3"	"Cell type enriched"	"Detected in some"	87	"Plasma cells: 5993.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;Daudi: 3.7;K-562: 2.4;NB-4: 1.7;TIME: 3.3"									HPA006014	Approved				"Immunoglobulin genes"	NA	NA		2700000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 64: Macrophages - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA006014: "	"unprognostic (2.03e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.80e-2)"	"prognostic favorable (5.47e-4)"	"unprognostic (2.40e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.92e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (3.31e-7)"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.17e-1)"	20.0	4.8	0.3	0.0	0.0	0.0	25.9	0.1	1.7	17.8	0.7	245.7	0.0	8.6	6.3	19.1	15.2	27.1	2.1	0.1	0.7	15.4	15.0	56.2	0.0	0.9	0.0	8.8	17.1	1.0	2.2	0.6	0.2	11.2	0.0	0.0	224.5	0.0	0.7	3.2	144.8	1.7	0.6	547.1	99.9	4.8	0.1	0.0	25.6	0.0	0.0	353.3	14.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	1.3	0.8	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.3	1.3	1.2	0.8	0.0	0.1	0.0	0.7	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	1.7	0.1	0.7	0.9	0.0	0.2	0.6	0.1	1.3	0.0	0.0	0.0	0.0	68.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	1.8	44.9	0.0	0.0	0.0	0.7	1.0	0.1	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5993.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0
IGHV6-1		ENSG00000211933	"Immunoglobulin heavy variable 6-1"	A0A0B4J1U7	14	105939756-105940253	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 441.3;lymphoid tissue: 159.0"	"Cell type enriched"	"Detected in some"	175	"Plasma cells: 2295.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	6	"naive B-cell: 19.7"	"Lineage enriched"	"Detected in single"	53	"B-cells: 19.7"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA		930000000	"Cluster 24: B-cells - Unknown function"	"Cluster 14: B-cells - Humoral immune response"		"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (1.35e-4)"	"unprognostic (9.66e-2)"	"unprognostic (4.55e-3)"	"unprognostic (1.26e-1)"		"prognostic favorable (1.85e-5)"		"unprognostic (1.84e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.95e-1)"	"prognostic unfavorable (2.48e-6)"	"unprognostic (3.69e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-1)"	13.0	2.1	0.3	0.0	0.1	0.0	7.5	0.0	0.4	4.2	0.2	441.3	0.0	1.2	0.0	17.9	4.3	1.5	2.7	0.0	0.1	3.2	6.2	13.6	0.0	0.3	0.1	0.9	11.5	0.0	0.3	0.0	0.1	1.6	0.0	0.0	56.7	8.6	0.1	2.0	40.9	11.2	0.3	159.0	19.5	0.3	0.2	0.0	6.8	0.0	0.0	3.7	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.7	0.7	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.1	19.7	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.0	0.1	0.3	0.1	0.1	0.3	0.2	0.2	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.1	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2295.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0
IGKJ3		ENSG00000211595	"Immunoglobulin kappa joining 3"		2	88861221-88861258	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 1010.8;lymphoid tissue: 997.2;stomach 1: 710.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	12	"spinal cord: 18.3"	"Group enriched"	"Detected in all"	26	"memory B-cell: 8663.4;naive B-cell: 7153.9"	"Lineage enriched"	"Detected in all"	28	"B-cells: 8663.4"	"Group enriched"	"Detected in some"	6	"HDLM-2: 105.2;RPMI-8226: 89.2;U-698: 41.2"															NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 44: HDLM-2 - Immune response"																						15.1	19.6	0.8	886.7	0.7	115.0	111.2	0.3	1.3	19.2	0.5	587.3	1010.8	7.6	0.0	68.8	7.9	44.8	9.3	0.9	0.6	14.3	41.1	101.9	490.2	1.2	0.5	31.1	0.0	0.0	0.0	1.9	1.5	18.2	546.6	0.6	362.3	12.6	8.7	2.5	726.3	19.9	18.3	548.6	710.1	9.7	0.9	53.9	5.1	3.9	997.2	236.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	105.2	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	89.2	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.9	0.0	0.0	41.2	0.0	0.0	0.0	17.0	8.6	57.9	1.9	1.1	9.2	8663.4	3.0	3.3	5.9	7153.9	5.7	5.1	61.8	7.1	15.2	309.9	7.8	660.0	0.8	0.7	0.3	1.3	0.9	0.6	1.2	0.5	1.5	18.3	0.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKJ4		ENSG00000211594	"Immunoglobulin kappa joining 4"		2	88860886-88860922	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 3282.9;lymphoid tissue: 2905.5;stomach 1: 2295.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	42	"memory B-cell: 36413.7;naive B-cell: 27723.7"	"Lineage enriched"	"Detected in all"	48	"B-cells: 36413.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 16.9;Daudi: 23.5;HDLM-2: 58.4;RPMI-8226: 43.3;SH-SY5Y: 27.6;U-698: 25.7"															NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 44: HDLM-2 - Immune response"																						80.0	268.7	0.6	2905.5	0.7	407.6	414.6	0.3	4.1	110.0	0.5	1844.1	3282.9	29.5	62.5	433.0	33.3	138.1	34.8	0.6	1.1	48.2	104.6	481.3	932.6	2.9	0.7	117.5	29.3	1.7	0.0	1.3	1.3	56.4	1849.6	0.3	1142.3	54.8	3.9	17.3	2184.0	78.1	2.6	1246.0	2295.9	39.7	1.8	113.5	11.4	0.0	2661.5	645.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.4	0.0	0.0	0.0	0.0	0.0	9.1	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	2.0	10.4	0.0	0.0	0.0	0.0	9.1	43.3	0.0	0.0	6.7	27.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	7.3	8.5	3.3	0.0	25.7	0.0	0.0	0.0	114.4	64.9	20.3	24.9	9.5	16.8	36413.7	15.8	15.2	32.5	27723.7	22.7	16.1	60.0	21.5	25.4	759.9	22.8	3519.3	0.6	0.7	0.3	4.1	0.6	1.1	2.9	0.7	1.3	2.6	1.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKJ5		ENSG00000211593	"Immunoglobulin kappa joining 5"		2	88860568-88860605	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in many"	4	"intestine: 1221.3;lymphoid tissue: 1365.8;salivary gland: 643.7;stomach 1: 1066.6;urinary bladder: 436.6"	"Cell type enriched"	"Detected in single"	13	"B-cells: 1.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	24	"memory B-cell: 9254.1;naive B-cell: 8737.5"	"Lineage enriched"	"Detected in all"	25	"B-cells: 9254.1"	"Cell line enriched"	"Detected in some"	24	"U-698: 3392.4"															NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"				"unprognostic (4.92e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.68e-2)"	"unprognostic (9.30e-3)"		"prognostic favorable (1.83e-4)"		"unprognostic (1.12e-1)"			"unprognostic (3.22e-1)"		"prognostic unfavorable (5.49e-6)"	"unprognostic (2.00e-2)"	"unprognostic (4.25e-1)"		"unprognostic (2.02e-1)"	25.2	42.2	0.5	1365.8	0.7	164.5	236.5	0.6	4.5	73.7	0.3	1194.4	1221.3	13.4	5.8	130.7	8.8	78.5	26.1	0.9	0.7	18.0	30.8	157.6	529.7	1.6	0.6	63.3	29.2	6.6	0.0	4.1	1.2	22.8	1171.9	0.0	643.7	17.1	0.0	5.8	1078.7	40.6	4.9	672.7	1066.6	12.4	0.7	61.5	4.3	0.0	1213.5	436.6	0.0	0.9	17.7	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	142.3	0.0	0.0	0.0	0.0	0.0	7.2	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	58.5	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	133.3	3.5	11.4	3.2	1.9	3392.4	0.0	8.1	0.0	3.3	10.1	10.2	3.8	1.3	2.2	9254.1	18.4	3.5	7.4	8737.5	9.5	3.4	9.4	7.6	3.4	373.6	8.8	1167.3	0.5	0.7	0.6	4.5	0.9	0.7	1.6	0.6	1.2	4.9	0.7	0.9	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV1-12	"IGKV112, L19"	ENSG00000243290	"Immunoglobulin kappa variable 1-12"	A0A0C4DH73	2	89040224-89040745	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"intestine: 395.8;lymphoid tissue: 788.8"	"Cell type enriched"	"Detected in some"	92	"Plasma cells: 12442.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 17.2"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	820	"memory B-cell: 259.8;naive B-cell: 164.2"	"Lineage enriched"	"Detected in single"	1005	"B-cells: 259.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;Daudi: 2.1;RPMI-8226: 1.9;SH-SY5Y: 1.9"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		13000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (6.09e-4)"	"prognostic favorable (1.59e-4)"	"unprognostic (7.33e-2)"	"unprognostic (3.74e-2)"		"prognostic favorable (3.85e-5)"		"unprognostic (5.89e-2)"	"unprognostic (5.74e-1)"	"unprognostic (7.13e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.90e-1)"	"prognostic unfavorable (6.59e-8)"	"unprognostic (1.18e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.71e-1)"	13.6	144.8	0.0	201.7	0.2	73.1	116.8	0.0	0.4	50.8	0.2	395.8	240.6	7.3	0.0	57.1	16.2	69.6	9.9	0.1	0.1	13.7	17.8	65.3	238.6	0.6	0.0	18.1	7.2	0.2	1.4	0.0	1.1	7.2	278.6	0.0	219.0	5.4	0.4	2.8	231.2	11.2	1.2	360.5	254.9	6.7	0.0	69.5	32.7	0.0	788.8	243.3	9.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.1	0.1	0.0	0.0	259.8	0.0	0.1	0.1	164.2	0.0	0.1	0.2	0.1	0.1	0.1	0.1	24.3	0.0	0.2	0.0	0.4	0.1	0.1	0.6	0.0	1.1	1.2	0.0	0.3	0.0	0.0	0.0	0.0	134.3	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.2	1.3	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	20.4	0.0	0.0	0.0	1.8	1.6	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.3	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12442.9	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.3	0.0	0.3	5.0	0.0	0.0	0.0
IGKV1-16	"IGKV116, L1"	ENSG00000240864	"Immunoglobulin kappa variable 1-16"	P04430	2	89099859-89100361	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 279.7;lymphoid tissue: 597.8;urinary bladder: 260.3"	"Cell type enriched"	"Detected in some"	559	"Plasma cells: 18463.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	523	"memory B-cell: 164.7;naive B-cell: 112.8"	"Lineage enriched"	"Detected in single"	621	"B-cells: 164.7"	"Cell line enhanced"	"Detected in single"		"RPMI-8226: 1.0"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		10000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (2.63e-4)"	"unprognostic (7.81e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.61e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.35e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (2.84e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.84e-2)"	"unprognostic (5.82e-2)"	11.8	4.7	0.1	159.1	0.1	40.0	75.9	0.0	0.8	76.0	0.6	279.7	199.4	6.3	0.5	34.3	6.6	99.0	11.4	0.0	0.1	9.2	14.9	40.5	155.0	0.2	0.0	17.7	2.0	0.1	3.6	0.1	0.1	5.6	235.6	0.0	126.9	30.9	0.8	0.7	143.6	11.8	0.1	315.4	158.9	2.0	0.1	45.7	18.4	0.0	597.8	260.3	5.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.1	0.2	1.0	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	164.7	0.0	0.0	0.1	112.8	0.0	0.1	0.2	0.0	0.0	0.0	0.0	16.9	0.1	0.1	0.0	0.8	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	33.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.6	21.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18463.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	0.0
IGKV1-17	"A30, IGKV117"	ENSG00000240382	"Immunoglobulin kappa variable 1-17"	P01599	2	89117342-89117844	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 375.0;lymphoid tissue: 454.4"	"Cell type enriched"	"Detected in some"	113	"Plasma cells: 4510.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	425	"memory B-cell: 105.7;naive B-cell: 82.2"	"Lineage enriched"	"Detected in single"	478	"B-cells: 105.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.9;K-562: 1.2;RPMI-8226: 2.0;SH-SY5Y: 1.4"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		8400000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"unprognostic (7.72e-3)"	"unprognostic (1.60e-1)"	"unprognostic (7.37e-3)"	"unprognostic (1.78e-2)"	"unprognostic (5.08e-3)"	"prognostic favorable (4.11e-4)"	"unprognostic (8.04e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (3.44e-7)"	"unprognostic (3.12e-3)"	"unprognostic (8.83e-2)"	"unprognostic (3.80e-1)"	"unprognostic (7.28e-2)"	12.8	26.5	0.1	183.7	0.2	27.7	87.1	0.0	0.7	11.9	0.4	358.5	294.8	6.6	4.1	54.7	12.4	55.7	10.9	0.0	0.1	10.3	14.2	36.5	95.7	0.6	0.0	12.4	3.3	1.1	1.0	0.1	0.2	5.5	375.0	0.0	134.3	31.0	1.3	1.2	152.7	4.7	0.1	306.1	159.7	2.4	0.3	45.6	25.8	0.0	454.4	182.6	6.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.8	2.0	0.0	0.0	0.5	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	105.7	0.0	0.0	0.1	82.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	12.6	0.1	0.2	0.0	0.7	0.0	0.1	0.6	0.0	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	39.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	11.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4510.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0
IGKV1-27	"A20, IGKV127"	ENSG00000244575	"Immunoglobulin kappa variable 1-27"	A0A075B6S5	2	89213423-89213928	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 268.0;lymphoid tissue: 347.1;salivary gland: 177.6"	"Cell type enriched"	"Detected in some"	126	"Plasma cells: 4951.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	683	"memory B-cell: 152.7;naive B-cell: 185.3"	"Lineage enriched"	"Detected in single"	748	"B-cells: 185.3"	"Cell line enhanced"	"Detected in single"		"BEWO: 1.8"					"Not detected"	"Not detected"			HPA048721	Approved				"Immunoglobulin genes"	NA	NA		8300000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (2.56e-5)"	"unprognostic (6.50e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.72e-2)"	"prognostic favorable (8.14e-4)"	"unprognostic (9.60e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.99e-3)"	"unprognostic (9.31e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (8.84e-5)"	"unprognostic (3.23e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.67e-2)"	17.2	9.2	0.0	133.5	0.0	28.5	70.0	0.0	0.4	16.8	0.1	268.0	183.3	6.2	7.7	30.4	6.9	37.5	10.7	0.1	0.1	11.8	9.7	55.2	124.7	0.7	0.3	8.8	4.9	0.2	1.0	0.0	0.1	6.4	212.3	0.0	177.6	8.8	0.6	0.9	200.2	5.1	0.2	276.9	91.9	1.0	0.0	46.9	19.4	0.0	347.1	87.7	6.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.4	0.6	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.1	152.7	0.1	0.1	0.1	185.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	15.8	0.0	0.0	0.0	0.4	0.1	0.1	0.7	0.3	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	39.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.3	12.2	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4951.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0
IGKV1-33	"IGKV133, O18"	ENSG00000242076	"Immunoglobulin kappa variable 1-33"	P01594	2	89266494-89268506	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Bence-Jones protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 1727.5;stomach 1: 627.3;urinary bladder: 623.3"	"Cell type enriched"	"Detected in some"	131	"Plasma cells: 2044.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 5.5"	"Region enriched"	"Detected in many"	7	"spinal cord: 12.0"	"Group enriched"	"Detected in some"	378	"memory B-cell: 369.6;naive B-cell: 441.5"	"Lineage enriched"	"Detected in many"	411	"B-cells: 441.5"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 2.7;SCLC-21H: 9.1;SH-SY5Y: 8.8;U-251 MG: 3.5"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"unprognostic (1.76e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.52e-2)"			"prognostic favorable (4.58e-5)"		"unprognostic (5.06e-2)"		"unprognostic (8.55e-3)"	"unprognostic (2.31e-1)"			"unprognostic (1.63e-2)"	"unprognostic (2.57e-1)"		"unprognostic (4.66e-1)"	50.5	21.9	0.1	266.2	0.5	139.5	320.5	0.6	1.0	129.8	0.4	471.5	296.2	20.7	2.8	106.2	33.4	187.2	23.2	0.2	1.6	36.7	37.9	130.4	529.5	0.4	1.0	37.0	8.3	1.9	2.7	0.4	0.7	18.7	511.9	0.2	476.4	127.7	0.7	2.5	175.9	14.5	12.0	820.8	627.3	13.5	0.2	381.9	53.9	0.2	1727.5	623.3	26.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.1	1.9	2.7	0.0	0.0	9.1	8.8	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.4	3.5	0.7	0.0	0.2	0.0	0.6	0.0	0.4	0.3	0.4	0.1	0.0	0.1	369.6	0.2	0.1	0.3	441.5	0.2	0.1	1.0	0.2	0.3	0.3	0.2	39.5	0.1	0.5	0.6	1.0	0.2	1.6	0.4	1.0	0.7	12.0	0.2	1.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2044.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0
IGKV1-39		ENSG00000242371	"Immunoglobulin kappa variable 1-39"	P01597	2	89319625-89320146	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 108.5;lymphoid tissue: 254.9;salivary gland: 151.2;stomach 1: 83.2"	"Cell type enriched"	"Detected in some"	151	"Plasma cells: 16225.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 13.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	388	"memory B-cell: 1069.8;naive B-cell: 935.1"	"Lineage enriched"	"Detected in many"	415	"B-cells: 1069.8"	"Cell line enriched"	"Detected in some"	21	"Daudi: 194.2"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		8000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (1.76e-4)"	"unprognostic (5.10e-3)"	"unprognostic (4.71e-2)"			"prognostic favorable (1.70e-5)"		"unprognostic (2.38e-1)"		"unprognostic (7.33e-2)"	"unprognostic (1.78e-1)"		"unprognostic (6.62e-6)"	"unprognostic (1.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.27e-1)"	"unprognostic (2.25e-1)"	10.9	9.1	0.0	54.7	0.1	14.2	17.7	0.0	0.1	21.8	0.0	108.5	70.5	5.7	0.0	11.6	12.5	14.3	1.5	0.2	0.0	10.9	6.8	27.2	36.5	0.0	0.0	1.8	3.2	0.0	0.5	0.0	0.2	4.2	13.3	0.0	151.2	0.9	0.2	1.3	74.4	1.2	0.0	254.9	83.2	0.3	0.0	5.9	31.0	0.0	42.5	17.5	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	194.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	1.8	0.0	9.0	0.0	0.0	0.0	0.9	1.0	0.7	0.3	0.3	0.3	1069.8	0.5	0.4	1.1	935.1	0.3	0.6	2.5	0.4	0.6	1.3	0.8	136.4	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	10.7	0.0	0.0	0.0	0.4	3.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16225.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	4.9	0.0	0.3	0.0
IGKV1-8	"IGKV18, L9"	ENSG00000240671	"Immunoglobulin kappa variable 1-8"	A0A0C4DH67	2	88992409-88992931	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 29.7;lymphoid tissue: 55.0;salivary gland: 21.2;stomach 1: 18.6;urinary bladder: 41.7"	"Cell type enriched"	"Detected in some"	40	"Plasma cells: 622.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	311	"memory B-cell: 131.0;naive B-cell: 136.4"	"Lineage enriched"	"Detected in single"	317	"B-cells: 136.4"	"Not detected"	"Not detected"											HPA048721	Approved				"Immunoglobulin genes"	NA	NA		6100000000	"Cluster 37: B-cells - Transcription"	"Cluster 14: B-cells - Humoral immune response"		"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (1.64e-4)"	"unprognostic (1.56e-2)"	"unprognostic (8.07e-2)"	"unprognostic (6.41e-3)"		"prognostic favorable (5.13e-4)"	"unprognostic (6.87e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (4.14e-7)"	"unprognostic (6.94e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.98e-1)"	2.1	2.5	0.0	13.5	0.0	7.1	6.7	0.0	0.1	2.0	0.0	29.7	12.0	1.3	0.0	2.9	1.4	5.4	1.5	0.0	0.0	3.3	2.1	4.8	13.7	0.0	0.0	0.5	0.9	0.0	0.1	0.0	0.0	1.4	19.3	0.0	21.2	0.7	0.0	0.1	13.9	0.6	0.0	51.3	18.6	0.3	0.0	7.0	3.3	0.0	55.0	41.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	131.0	0.0	0.4	0.1	136.4	0.1	0.0	0.1	0.1	0.1	0.0	0.1	12.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	622.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0
IGKV2-28		ENSG00000244116	"Immunoglobulin kappa variable 2-28"	A0A075B6P5	2	89221698-89222461	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1044.6;lymphoid tissue: 1735.3"	"Cell type enriched"	"Detected in some"	92	"Plasma cells: 1868.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	13	"naive B-cell: 11.1"	"Lineage enriched"	"Detected in single"	13	"B-cells: 11.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.4;Daudi: 2.8;HL-60: 3.6;K-562: 2.0;NB-4: 2.7;RPMI-8226: 4.5;SCLC-21H: 2.1;SH-SY5Y: 1.7"														"Immunoglobulin genes"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.03e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.34e-1)"			"prognostic favorable (3.32e-4)"		"unprognostic (2.12e-2)"		"unprognostic (6.32e-3)"	"unprognostic (3.14e-1)"			"unprognostic (3.71e-2)"	"unprognostic (5.21e-2)"		"unprognostic (2.64e-2)"	36.2	40.2	0.2	402.4	0.2	180.2	425.2	0.1	1.1	56.6	0.9	1044.6	756.7	38.2	4.9	662.7	29.0	130.8	22.3	0.1	0.3	46.2	40.2	157.6	584.6	0.6	0.9	87.9	19.5	3.8	3.3	0.5	0.3	21.1	709.6	0.1	732.4	95.0	1.8	7.1	425.6	23.9	0.8	1207.7	530.0	161.9	0.2	167.6	84.8	0.0	1735.3	494.1	30.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.7	0.4	0.0	0.0	0.0	1.1	4.5	0.0	0.4	2.1	1.7	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.9	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.4	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.2	11.1	0.2	0.1	0.8	0.1	0.0	0.4	0.1	0.0	0.2	0.2	0.1	1.1	0.1	0.3	0.6	0.9	0.3	0.8	0.2	0.9	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1868.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	20.3	0.0	0.0	0.0
IGKV2-30		ENSG00000243238	"Immunoglobulin kappa variable 2-30"	P06310	2	89244781-89245596	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 631.0;lymphoid tissue: 670.2;stomach 1: 323.1"	"Cell type enriched"	"Detected in some"	365	"Plasma cells: 25365.6"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 26.0"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	316	"memory B-cell: 561.0;naive B-cell: 325.4"	"Lineage enriched"	"Detected in many"	400	"B-cells: 561.0"	"Cell line enriched"	"Detected in some"	388	"U-698: 8426.0"														"Immunoglobulin genes"	NA	NA		6800000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (6.84e-5)"	"unprognostic (1.26e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.41e-1)"		"prognostic favorable (6.78e-5)"	"unprognostic (6.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.45e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.07e-1)"	"prognostic unfavorable (4.53e-6)"	"unprognostic (1.74e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.50e-1)"	15.0	9.4	0.1	160.7	0.2	75.9	237.0	0.1	1.3	19.6	0.7	631.0	394.3	5.6	0.8	37.8	11.5	35.0	17.9	0.1	0.1	15.1	29.6	67.3	176.7	1.4	0.1	15.8	7.8	0.1	2.3	0.2	0.2	7.8	324.5	0.0	220.5	23.3	0.6	2.0	260.2	19.1	0.6	670.2	323.1	21.2	0.1	40.9	18.8	0.0	600.3	207.5	21.5	1.1	5.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	13.1	4.6	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	1.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.8	0.3	0.0	0.0	0.1	2.7	1.9	0.0	0.4	0.0	0.9	3.8	0.0	2.6	0.0	0.0	5.6	0.0	0.0	21.7	0.1	2.6	0.3	1.7	8426.0	0.0	2.7	0.0	0.5	0.4	0.2	0.2	0.0	0.2	561.0	0.1	0.2	0.4	325.4	0.0	0.2	1.4	0.2	0.3	0.7	0.3	53.3	0.1	0.2	0.1	1.3	0.1	0.1	1.4	0.1	0.2	0.6	0.1	1.1	0.0	0.0	0.0	0.0	69.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.3	30.5	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25365.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.2	0.0	0.3	0.0
IGKV3-11		ENSG00000241351	"Immunoglobulin kappa variable 3-11"	P04433	2	89027171-89027731	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1373.3;lymphoid tissue: 2812.9;urinary bladder: 1822.6"	"Cell type enriched"	"Detected in some"	129	"Plasma cells: 27475.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	9	"spinal cord: 19.8"	"Group enriched"	"Detected in many"	292	"memory B-cell: 1729.8;naive B-cell: 1401.2"	"Lineage enriched"	"Detected in many"	323	"B-cells: 1729.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.0;Daudi: 2.0;SCLC-21H: 3.7;SH-SY5Y: 4.6"									HPA047702	Approved				"Immunoglobulin genes"	NA	NA		18000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA047702: "	"unprognostic (3.97e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.70e-2)"	"prognostic favorable (1.36e-5)"	"unprognostic (2.02e-1)"	"unprognostic (3.20e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (2.26e-8)"	"unprognostic (5.93e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	45.8	60.5	0.4	733.2	0.3	189.1	385.3	0.2	2.1	136.2	0.6	1373.3	701.6	32.1	11.5	143.5	34.0	253.5	18.9	0.2	0.6	44.4	55.2	227.4	575.7	0.6	0.7	120.8	13.7	1.9	3.2	0.9	0.9	30.1	1090.9	0.1	496.0	60.9	1.2	14.2	536.0	59.5	19.8	1100.0	788.6	22.2	0.3	261.9	88.8	0.9	2812.9	1822.6	33.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.2	0.4	0.0	0.0	0.4	1.8	1.5	0.0	0.0	3.7	4.6	0.4	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.7	0.7	0.6	1.8	0.3	0.1	0.0	1.4	0.0	1.9	1.3	1.2	2.0	0.2	0.7	1729.8	0.8	0.6	1.6	1401.2	0.8	0.8	5.3	0.9	1.1	1.2	1.3	186.7	0.4	0.3	0.2	2.1	0.2	0.6	0.6	0.7	0.9	19.8	0.3	1.0	0.0	0.0	0.5	0.0	211.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	82.6	0.0	0.0	0.0	2.5	1.9	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.7	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27475.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	62.0	0.0	0.3	0.0
IGKV3-15		ENSG00000244437	"Immunoglobulin kappa variable 3-15"	P01624	2	89085177-89085787	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 785.8;lymphoid tissue: 1996.3;urinary bladder: 784.8"	"Cell type enriched"	"Detected in some"	85	"Plasma cells: 22923.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	561	"memory B-cell: 2243.8;naive B-cell: 1651.4"	"Lineage enriched"	"Detected in all"	646	"B-cells: 2243.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.7;K-562: 1.3;NB-4: 1.9;RH-30: 1.2;RPMI-8226: 2.2;SCLC-21H: 1.4;SH-SY5Y: 2.5"									HPA047702	Approved				"Immunoglobulin genes"	NA	NA		7200000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA047702: "	"prognostic favorable (1.57e-4)"	"unprognostic (1.29e-2)"	"unprognostic (7.02e-3)"	"unprognostic (3.89e-3)"	"unprognostic (9.06e-3)"	"unprognostic (2.06e-3)"	"unprognostic (5.36e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.82e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (3.15e-7)"	"unprognostic (2.00e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.17e-1)"	47.9	114.5	0.0	603.8	0.1	131.0	174.3	0.0	1.5	141.8	0.3	785.8	431.4	19.4	34.7	120.0	30.0	144.4	14.8	0.1	0.3	35.2	36.7	184.8	500.9	0.7	0.3	55.4	9.3	2.5	3.0	0.5	0.3	18.3	649.4	0.0	399.3	114.2	1.0	2.7	335.8	29.5	1.5	1020.7	629.8	64.8	0.2	250.2	77.7	0.0	1996.3	784.8	28.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.4	1.9	0.6	0.0	0.0	0.0	1.2	2.2	0.0	0.0	1.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.4	0.7	0.5	0.0	0.0	0.0	1.0	0.0	1.8	3.4	0.8	1.0	0.4	0.8	2243.8	1.0	1.1	1.8	1651.4	1.0	1.1	1.9	1.0	1.3	1.7	1.5	193.1	0.0	0.1	0.0	1.5	0.1	0.3	0.7	0.3	0.3	1.5	0.2	1.0	0.0	0.0	0.0	0.0	269.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	2.6	73.4	0.0	0.0	0.0	1.4	1.1	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	22923.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	252.5	0.0	0.0	0.2	0.0	0.0	28.2	0.0	0.0	0.0
IGKV4-1	"B3, IGKV41"	ENSG00000211598	"Immunoglobulin kappa variable 4-1"	P06312	2	88885397-88886153	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1805.7;lymphoid tissue: 3169.0"	"Cell type enriched"	"Detected in some"	219	"Plasma cells: 46306.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	588	"memory B-cell: 3036.3;naive B-cell: 3070.9"	"Lineage enriched"	"Detected in all"	591	"B-cells: 3070.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 14.9;RPMI-8226: 10.4;SH-SY5Y: 6.9;U-266/70: 7.5"														"Immunoglobulin genes"	NA	NA		8500000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (6.41e-5)"	"unprognostic (9.19e-2)"	"unprognostic (4.29e-3)"	"unprognostic (5.42e-3)"	"unprognostic (2.08e-2)"	"prognostic favorable (8.25e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.32e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.29e-1)"	"prognostic unfavorable (2.52e-6)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.19e-1)"	55.9	296.3	0.4	1054.1	0.9	342.1	665.2	0.4	3.4	145.2	2.4	1805.7	1769.7	46.8	19.4	195.7	41.3	188.2	51.9	0.4	1.2	35.0	76.1	302.3	816.8	1.9	0.8	86.5	28.3	2.5	2.8	1.0	3.5	43.9	1318.2	0.1	701.8	89.6	1.0	8.6	1023.0	66.4	3.6	972.3	1125.7	125.7	0.7	405.1	51.0	0.1	3169.0	758.2	19.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.9	0.0	1.7	0.0	0.0	0.0	3.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.6	3.6	0.3	0.0	0.0	1.4	2.2	10.4	0.0	0.0	4.0	6.9	2.3	0.0	0.0	0.0	0.0	0.7	2.6	0.0	0.8	1.1	1.0	7.5	0.2	0.8	0.0	1.2	0.0	3.9	3.2	5.1	1.6	0.9	1.7	3036.3	1.9	1.1	2.8	3070.9	2.1	1.3	2.4	1.6	2.4	2.3	1.7	344.9	0.4	0.9	0.4	3.4	0.4	1.2	1.9	0.8	3.5	3.6	0.7	1.5	0.0	0.0	0.0	0.0	210.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	8.0	0.0	0.0	0.0	17.0	40.2	0.0	0.0	0.0	2.2	2.8	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	46306.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	15.7	0.0	0.1	0.0
IGLJ2		ENSG00000211676	"Immunoglobulin lambda joining 2"		22	22899481-22899655	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 260.8;lymphoid tissue: 189.8;stomach 1: 212.7"	"Cell type enriched"	"Detected in single"	5	"Plasma cells: 1.7"	"Group enriched"	"Detected in many"	8	"colorectal cancer: 12.9;endometrial cancer: 21.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	12	"memory B-cell: 876.1;naive B-cell: 864.5"	"Lineage enriched"	"Detected in many"	12	"B-cells: 876.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 10.8;HMC-1: 34.1;RH-30: 89.7;U-698: 19.8"															NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (6.99e-3)"	"unprognostic (5.36e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.13e-2)"		"unprognostic (5.94e-7)"		"unprognostic (1.51e-2)"			"unprognostic (3.63e-2)"			"unprognostic (3.66e-2)"	"unprognostic (5.17e-2)"		"unprognostic (2.92e-1)"	8.4	54.9	0.2	173.0	0.0	25.4	11.2	0.1	0.8	6.1	0.1	134.5	260.8	2.9	4.2	13.5	1.0	12.5	2.9	0.1	0.2	2.1	6.9	21.5	94.5	0.3	0.0	4.7	5.9	0.1	0.0	0.0	0.9	4.0	31.1	0.0	75.6	4.2	0.0	0.2	206.0	1.9	0.1	128.3	212.7	2.3	0.0	15.5	0.3	0.0	189.8	60.8	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.7	89.7	1.3	0.0	0.0	0.8	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	1.0	0.0	0.6	19.8	0.0	0.5	0.0	1.4	1.9	0.6	0.4	0.2	0.7	876.1	0.3	0.3	0.9	864.5	0.2	0.4	9.3	0.7	0.8	71.8	0.5	136.5	0.2	0.0	0.1	0.8	0.1	0.2	0.3	0.0	0.9	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGLJ3		ENSG00000211678	"Immunoglobulin lambda joining 3"		22	22904850-22905025	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in many"	7	"intestine: 552.2;lymphoid tissue: 227.6;salivary gland: 149.1;stomach 1: 462.5;urinary bladder: 147.8"	"Group enriched"	"Detected in some"	44	"B-cells: 4.5;Plasma cells: 4.3"	"Group enriched"	"Detected in some"	13	"colorectal cancer: 5.1;endometrial cancer: 10.3"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.5"	"Group enriched"	"Detected in many"	24	"memory B-cell: 1223.9;naive B-cell: 1139.6"	"Lineage enriched"	"Detected in many"	25	"B-cells: 1223.9"	"Group enriched"	"Detected in some"	7	"Daudi: 53.6;REH: 69.6;U-266/70: 42.8;U-266/84: 22.5"															NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 57: B-cells - Immune response"						"unprognostic (1.19e-1)"	"unprognostic (2.06e-3)"				"unprognostic (2.05e-1)"						"unprognostic (1.37e-1)"	"unprognostic (5.00e-1)"			5.7	29.4	0.4	212.4	0.3	37.4	32.5	0.1	1.5	9.7	0.4	130.1	552.2	3.2	0.0	40.0	4.0	32.7	3.1	0.1	0.1	2.9	9.9	41.7	132.1	0.4	0.2	31.1	1.9	0.0	0.0	0.1	0.1	9.6	71.4	0.0	149.1	1.6	0.0	1.5	205.9	6.1	0.0	207.6	462.5	6.1	0.1	23.2	0.8	0.0	227.6	147.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	53.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	69.6	2.5	6.7	0.0	0.0	0.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	1.0	42.8	22.5	4.3	0.0	0.0	0.0	0.8	1.6	0.7	0.9	0.3	4.3	1223.9	0.8	0.5	1.3	1139.6	0.4	0.5	8.5	0.6	1.2	49.2	0.8	193.9	0.4	0.3	0.1	1.5	0.1	0.1	0.4	0.2	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGLV1-40		ENSG00000211653	"Immunoglobulin lambda variable 1-40"	P01703	22	22409766-22410282	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 1291.5;stomach 1: 1287.4"	"Cell type enriched"	"Detected in some"	358	"Plasma cells: 43406.7"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.0"	"Group enriched"	"Detected in some"	496	"memory B-cell: 666.4;naive B-cell: 576.7"	"Lineage enriched"	"Detected in many"	532	"B-cells: 666.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 3.5;RPMI-8226: 2.2;SH-SY5Y: 3.4;TIME: 2.3"														"Immunoglobulin genes"	NA	NA		2300000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.64e-3)"	"unprognostic (4.68e-3)"	"unprognostic (3.88e-2)"	"unprognostic (3.37e-3)"	"unprognostic (9.60e-3)"	"prognostic favorable (5.74e-6)"	"unprognostic (2.39e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.43e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (5.44e-6)"	"unprognostic (1.51e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.57e-2)"	43.4	13.0	0.8	203.5	0.5	114.3	138.5	0.1	3.0	68.1	1.1	553.8	551.6	14.8	0.6	125.4	21.5	236.0	15.2	0.2	0.2	28.8	28.3	115.4	282.5	0.3	0.2	56.6	10.0	1.1	3.4	0.6	0.6	46.1	336.7	4.2	413.8	19.7	1.2	3.1	287.2	14.3	0.2	1029.8	1287.4	7.2	0.3	179.2	61.2	0.0	1291.5	464.8	19.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	1.0	1.1	0.0	0.0	0.2	0.8	2.2	0.0	0.0	1.3	3.4	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.4	0.7	0.7	1.1	1.1	0.8	0.0	0.3	0.0	0.4	0.7	0.2	0.3	0.1	0.6	666.4	0.3	0.3	0.6	576.7	0.1	0.2	1.2	0.3	0.3	0.6	0.4	53.7	0.8	0.5	0.1	3.0	0.2	0.2	0.3	0.2	0.6	0.2	0.3	1.0	0.0	0.0	0.0	0.0	121.0	0.0	0.0	0.0	2.2	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	1.2	8.0	0.0	0.0	0.0	28.6	64.2	0.0	0.0	0.0	1.8	0.9	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.7	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	43406.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	7.4	0.0	0.1	0.0
IGLV1-44		ENSG00000211651	"Immunoglobulin lambda variable 1-44"	P01699	22	22380766-22381347	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 589.7;lymphoid tissue: 1918.7;stomach 1: 534.3"	"Cell type enriched"	"Detected in some"	108	"Plasma cells: 12023.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	840	"memory B-cell: 968.8;naive B-cell: 850.4"	"Lineage enriched"	"Detected in many"	894	"B-cells: 968.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 21.3;RPMI-8226: 5.5;SCLC-21H: 4.1;U-698: 15.2"														"Immunoglobulin genes"	NA	NA		4000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.88e-3)"	"unprognostic (1.51e-2)"	"unprognostic (2.40e-2)"	"unprognostic (7.23e-3)"	"unprognostic (4.81e-3)"	"prognostic favorable (4.71e-5)"	"unprognostic (2.18e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (6.55e-8)"	"unprognostic (1.85e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.48e-2)"	"unprognostic (5.49e-2)"	33.9	2.0	0.1	297.2	0.0	133.4	110.2	0.0	0.8	14.3	0.0	378.7	589.7	11.8	0.0	80.1	19.5	78.7	17.5	0.0	0.0	18.7	17.1	122.2	519.5	1.3	0.2	15.3	3.6	0.0	2.6	0.0	0.4	13.8	263.1	0.0	273.0	9.4	0.7	2.4	236.5	21.4	0.0	608.7	534.3	11.6	0.1	117.8	35.1	0.0	1918.7	240.5	16.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	5.5	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	968.8	0.0	0.0	0.7	850.4	0.0	0.0	0.0	0.0	0.1	1.0	0.1	100.0	0.1	0.0	0.0	0.8	0.0	0.0	1.3	0.2	0.4	0.0	0.1	0.8	0.0	0.0	0.6	0.0	111.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.7	0.0	0.0	0.0	3.5	48.4	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12023.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.3	0.0
IGLV2-11		ENSG00000211668	"Immunoglobulin lambda variable 2-11"	P01706	22	22792491-22793007	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1542.6;lymphoid tissue: 2926.9"	"Cell type enriched"	"Detected in some"	85	"Plasma cells: 7693.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	37	"memory B-cell: 1402.5;naive B-cell: 850.1"	"Lineage enriched"	"Detected in many"	46	"B-cells: 1402.5"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 75.0;U-266/70: 20.9;U-266/84: 15.3"														"Immunoglobulin genes"	NA	NA		980000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (9.76e-3)"	"unprognostic (6.86e-2)"	"unprognostic (3.46e-3)"	"unprognostic (7.67e-3)"	"unprognostic (2.82e-3)"	"prognostic favorable (4.74e-5)"	"unprognostic (1.18e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (1.38e-7)"	"unprognostic (3.93e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.27e-1)"	33.6	7.3	0.6	344.7	0.3	157.3	447.8	0.1	2.7	27.7	0.8	1455.8	1542.6	18.4	0.5	212.0	30.0	191.3	44.6	0.2	0.7	22.4	41.1	179.8	680.1	1.5	0.2	30.5	22.4	0.6	2.1	0.5	1.1	17.0	868.3	0.0	425.0	36.0	1.7	2.9	713.8	21.3	0.6	637.7	876.1	75.4	0.5	286.4	62.2	0.0	2926.9	661.1	14.8	2.2	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	3.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	75.0	0.0	0.0	0.9	4.6	1.1	0.0	0.0	0.8	2.8	8.3	0.0	0.0	2.9	4.8	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	1.1	0.3	1.6	20.9	15.3	0.0	0.3	1.1	0.0	1.2	1.0	0.7	11.5	0.2	1.4	1402.5	1.5	5.9	0.9	850.1	1.0	4.6	30.2	11.1	0.8	0.9	0.8	149.8	0.6	0.3	0.1	2.7	0.2	0.7	1.5	0.2	1.1	0.6	0.5	2.2	0.0	0.0	0.0	0.0	89.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	15.8	0.0	0.0	0.0	1.4	11.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7693.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0
IGLV2-23		ENSG00000211660	"Immunoglobulin lambda variable 2-23"	P01705	22	22697789-22698407	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 691.1;lymphoid tissue: 1598.0;stomach 1: 672.8"	"Cell type enriched"	"Detected in some"	132	"Plasma cells: 12487.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	369	"memory B-cell: 2072.7;naive B-cell: 2596.0"	"Lineage enriched"	"Detected in all"	410	"B-cells: 2596.0"	"Cell line enriched"	"Detected in some"	10	"Karpas-707: 85411.7"														"Immunoglobulin genes"	NA	NA		540000000	"Cluster 24: B-cells - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (3.43e-5)"	"unprognostic (7.99e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.35e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.33e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.50e-7)"	"unprognostic (8.20e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.42e-2)"	16.0	38.9	0.7	306.7	0.3	103.6	184.7	0.1	1.5	45.2	0.6	634.1	691.1	16.2	1.3	78.7	25.5	66.8	19.9	0.2	0.1	18.6	26.2	160.8	623.2	1.0	0.1	16.3	8.2	0.6	1.7	0.6	0.4	10.8	457.1	0.0	356.7	38.1	0.5	2.1	517.3	16.1	0.3	530.5	672.8	5.9	0.2	277.6	39.1	0.4	1598.0	274.5	11.9	0.3	0.8	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.2	0.0	0.0	65.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.3	82.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	85411.7	0.0	0.0	2.2	4.2	0.5	0.0	0.0	0.7	1.9	8843.9	0.0	0.0	2.1	4.5	0.0	4.7	0.0	0.0	1.9	0.0	1.0	0.0	1.1	3.4	0.7	213.9	81.1	0.5	92.6	0.2	35.5	1.8	3.1	1.0	1.6	0.9	1.3	2072.7	1.6	0.8	2.6	2596.0	0.6	0.9	6.3	1.6	1.7	0.9	1.3	231.7	0.7	0.3	0.1	1.5	0.2	0.1	1.0	0.1	0.4	0.3	0.2	0.3	0.0	0.0	0.0	0.0	94.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	13.7	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12487.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	39.5	0.0	0.2	0.0
IGLV2-8		ENSG00000278196	"Immunoglobulin lambda variable 2-8"	P01709	22	22822658-22823289	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1141.8;lymphoid tissue: 1012.4"	"Cell type enriched"	"Detected in some"	80	"Plasma cells: 5288.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	125	"memory B-cell: 1439.0;naive B-cell: 2097.3"	"Lineage enriched"	"Detected in all"	149	"B-cells: 2097.3"	"Group enriched"	"Detected in many"	617	"U-266/70: 64161.5;U-266/84: 56786.5"														"Immunoglobulin genes"	NA	NA		1500000000	"Cluster 24: B-cells - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (2.92e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.65e-1)"	"prognostic favorable (5.07e-5)"	"unprognostic (2.74e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.55e-2)"	"prognostic unfavorable (3.00e-5)"	"unprognostic (2.04e-2)"	"unprognostic (2.67e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.62e-1)"	18.7	7.0	1.1	325.0	0.6	96.0	155.2	0.3	2.4	26.0	1.7	1141.8	977.0	9.4	3.5	91.4	7.9	132.4	30.5	0.3	0.3	15.4	24.3	59.2	228.2	0.8	0.3	57.2	30.3	1.4	1.4	0.2	0.7	9.0	250.6	0.0	255.5	60.3	0.6	1.9	451.5	20.1	0.8	437.7	433.9	3.4	0.3	90.6	23.7	0.0	1012.4	259.0	10.3	1.0	62.7	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	7.6	0.0	0.0	23.1	0.0	0.0	0.0	22.3	0.0	0.5	0.0	0.0	0.0	0.7	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.3	0.0	0.0	11.3	1.9	14.8	0.0	0.0	97.9	0.9	10.1	0.0	0.0	1.4	2.8	0.2	0.0	9.3	0.0	0.0	29.5	0.9	0.0	9.8	0.6	38.9	64161.5	56786.5	20.4	0.0	10.1	0.0	1.2	2.4	0.6	2.1	0.7	0.9	1439.0	1.3	1.5	1.9	2097.3	0.4	1.0	14.1	1.3	1.4	0.6	0.7	174.0	1.1	0.6	0.3	2.4	0.3	0.3	0.8	0.3	0.7	0.8	0.3	1.0	0.0	3.2	0.0	0.0	65.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	2.5	0.0	0.7	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5288.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.2	0.0
IGLV3-1		ENSG00000211673	"Immunoglobulin lambda variable 3-1"	P01715	22	22880706-22881396	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1234.9;lymphoid tissue: 3325.7;stomach 1: 1460.4"	"Cell type enriched"	"Detected in some"	321	"Plasma cells: 56277.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	725	"memory B-cell: 779.5;naive B-cell: 1038.5"	"Lineage enriched"	"Detected in many"	828	"B-cells: 1038.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 14.4;RPMI-8226: 4.5;SCLC-21H: 9.1;SH-SY5Y: 9.9"									HPA003285	Approved				"Immunoglobulin genes"	NA	NA		4300000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA003285: AB_1079122"	"prognostic favorable (9.70e-5)"	"unprognostic (9.06e-2)"	"unprognostic (5.39e-3)"	"unprognostic (2.37e-2)"	"unprognostic (8.13e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (2.30e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (9.06e-9)"	"unprognostic (2.70e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.69e-1)"	44.5	70.9	0.3	485.2	0.2	332.4	317.1	0.2	2.0	192.0	0.9	1234.9	643.4	39.2	0.0	217.7	19.2	310.4	28.1	0.1	0.4	26.3	70.1	176.2	1117.0	1.0	0.3	34.1	7.6	2.7	2.0	0.7	1.5	21.9	684.4	0.2	627.3	19.6	1.2	4.1	481.7	37.2	0.4	654.2	1460.4	56.0	0.3	335.5	35.9	0.0	3325.7	679.7	30.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.1	0.0	0.0	1.1	0.0	0.0	0.0	1.9	0.0	0.6	0.0	0.0	0.0	2.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.2	2.4	0.8	0.0	0.0	0.5	3.0	4.5	0.0	0.0	9.1	9.9	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.6	0.6	1.7	1.8	1.2	2.8	0.0	0.3	0.0	0.7	1.1	0.5	0.3	0.4	0.4	779.5	0.6	0.2	1.2	1038.5	0.2	0.3	0.6	0.4	0.8	0.5	0.5	52.3	0.3	0.2	0.2	2.0	0.1	0.4	1.0	0.3	1.5	0.4	0.3	0.9	0.0	3.2	0.0	0.0	111.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	122.5	0.0	0.0	0.0	0.0	0.0	10.7	174.8	0.0	0.0	0.0	1.1	1.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56277.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	11.7	0.0	0.2	0.0
IGLV3-10		ENSG00000211669	"Immunoglobulin lambda variable 3-10"	A0A075B6K4	22	22811747-22812281	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 317.0;lymphoid tissue: 707.7;stomach 1: 288.7"	"Cell type enriched"	"Detected in some"	52	"Plasma cells: 1090.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 3.3;medulla oblongata: 1.8"	"Group enriched"	"Detected in some"	786	"memory B-cell: 548.7;naive B-cell: 315.0"	"Lineage enriched"	"Detected in single"	998	"B-cells: 548.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.9;HL-60: 1.0;RH-30: 1.6"									HPA003285	Approved				"Immunoglobulin genes"	NA	NA		2000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA003285: AB_1079122"	"unprognostic (6.00e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.73e-2)"	"unprognostic (6.99e-2)"	"prognostic favorable (1.27e-4)"	"unprognostic (7.40e-3)"	"unprognostic (2.44e-2)"	"unprognostic (9.91e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.55e-1)"	"prognostic unfavorable (6.95e-8)"	"unprognostic (9.23e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.04e-2)"	33.3	112.9	0.5	144.0	0.4	65.5	111.1	0.1	3.3	41.3	0.6	308.0	176.3	7.6	4.5	56.3	7.9	43.5	20.5	0.1	0.2	12.2	20.8	48.0	230.5	1.8	0.2	14.6	10.8	0.9	0.8	0.4	0.6	11.0	317.0	0.0	139.7	10.8	0.2	8.1	94.9	5.8	0.1	217.1	288.7	97.4	0.2	25.9	8.6	0.0	707.7	140.2	7.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.2	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.5	0.3	0.3	0.2	0.0	0.2	548.7	0.1	0.2	0.2	315.0	0.0	0.2	0.3	0.1	0.1	0.3	0.1	43.2	0.5	0.4	0.1	3.3	0.1	0.2	1.8	0.2	0.6	0.1	0.2	0.2	0.0	0.0	0.6	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	7.1	0.0	1.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1090.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.2	0.0
IGLV3-19		ENSG00000211663	"Immunoglobulin lambda variable 3-19"	P01714	22	22720623-22721145	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1026.7;lymphoid tissue: 1979.7;stomach 1: 1240.2"	"Cell type enriched"	"Detected in some"	61	"Plasma cells: 3121.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	355	"memory B-cell: 618.3;naive B-cell: 503.7"	"Lineage enriched"	"Detected in many"	391	"B-cells: 618.3"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 6.2;SCLC-21H: 9.4;SH-SY5Y: 10.7;U-251 MG: 4.2"														"Immunoglobulin genes"	NA	NA		1200000000	"Cluster 37: B-cells - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (5.92e-5)"	"unprognostic (1.52e-2)"	"unprognostic (1.60e-3)"	"prognostic favorable (6.11e-5)"	"unprognostic (1.14e-1)"	"unprognostic (1.24e-3)"	"unprognostic (9.58e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (9.37e-10)"	"unprognostic (2.10e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.52e-2)"	49.1	20.1	0.1	402.2	0.3	185.1	313.5	0.1	2.4	69.2	0.3	1026.7	713.6	19.0	263.4	154.0	65.8	182.4	36.9	0.1	0.3	26.0	57.5	192.2	464.9	1.5	0.4	44.9	11.5	1.3	2.7	0.4	0.4	17.2	912.2	0.0	304.9	62.4	0.9	4.8	385.2	34.9	0.6	714.2	1240.2	6.0	0.4	435.0	55.4	0.0	1979.7	642.5	13.6	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	2.7	0.3	0.0	0.0	0.1	0.9	6.2	0.0	0.0	9.4	10.7	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.4	0.0	4.2	0.8	0.5	0.7	0.0	0.5	0.0	0.4	0.4	1.0	0.5	0.3	0.7	618.3	0.2	0.3	0.5	503.7	0.4	0.3	1.5	0.3	0.4	0.6	0.4	36.2	0.1	0.3	0.1	2.4	0.1	0.3	1.5	0.4	0.4	0.6	0.4	1.1	0.0	0.0	0.0	0.0	51.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	1.4	15.8	0.0	1.3	0.0	2.2	1.8	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3121.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0
IGLV3-21		ENSG00000211662	"Immunoglobulin lambda variable 3-21"	P80748	22	22711689-22713203	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 1812.1;urinary bladder: 773.9"	"Cell type enriched"	"Detected in some"	59	"Plasma cells: 5013.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	339	"memory B-cell: 432.0;naive B-cell: 224.7"	"Lineage enriched"	"Detected in single"	445	"B-cells: 432.0"	"Cell line enriched"	"Detected in some"	103	"REH: 282.7"														"Immunoglobulin genes"	NA	NA		4700000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 14: REH - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.75e-3)"	"unprognostic (6.04e-3)"	"unprognostic (4.21e-2)"	"unprognostic (2.59e-3)"	"unprognostic (4.06e-3)"	"prognostic favorable (3.26e-7)"	"unprognostic (1.63e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.30e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (9.54e-8)"	"unprognostic (7.83e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.67e-1)"	"unprognostic (7.52e-2)"	17.6	63.4	0.3	321.9	0.2	248.2	120.7	0.1	1.6	110.0	1.6	357.4	350.4	12.9	0.5	63.1	10.2	120.4	10.8	0.1	0.2	21.5	36.4	108.6	272.7	1.0	0.1	35.6	5.7	0.7	1.4	0.4	0.4	16.8	230.8	0.0	260.8	20.2	0.5	2.3	150.7	9.0	0.3	421.0	504.5	14.4	0.3	171.6	19.9	0.0	1812.1	773.9	17.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	2.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.4	0.5	0.2	0.0	0.0	282.7	1.8	2.0	0.0	0.0	1.6	1.8	0.1	0.3	0.0	0.0	0.0	0.0	2.2	0.0	0.3	0.5	0.5	0.5	0.1	0.2	0.0	0.2	0.0	0.2	0.2	0.1	0.1	0.0	0.1	432.0	0.1	0.1	0.3	224.7	0.1	0.1	0.9	0.1	0.1	0.2	0.1	36.6	0.3	0.2	0.1	1.6	0.1	0.2	1.0	0.1	0.4	0.3	0.3	1.3	0.0	0.0	0.0	0.0	84.4	0.0	0.0	0.0	4.6	0.0	0.1	0.0	0.1	2.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	4.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	20.4	0.0	0.0	0.0	3.3	2.5	0.1	0.0	0.0	0.0	0.0	1.3	0.0	4.7	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5013.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.2	0.0	0.0	1.8	0.0	0.2	0.0
IGLV6-57		ENSG00000211640	"Immunoglobulin lambda variable 6-57"	P01721	22	22195799-22196276	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 1814.6;urinary bladder: 675.2"	"Cell type enriched"	"Detected in some"	72	"Plasma cells: 10791.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"memory B-cell: 353.9;naive B-cell: 292.4"	"Lineage enriched"	"Detected in many"	13	"B-cells: 353.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 148.0;RPMI-8226: 40.6;U-266/70: 21.6;U-698: 47.3"														"Immunoglobulin genes"	NA	NA		1900000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (1.92e-6)"	"unprognostic (5.73e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (1.36e-5)"	"unprognostic (1.87e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.55e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (2.30e-6)"	"unprognostic (2.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.11e-1)"	15.6	9.1	0.0	220.8	0.1	191.7	215.5	0.0	0.6	82.3	0.4	485.0	351.3	19.1	4.4	171.4	38.2	75.8	39.2	0.1	0.0	10.7	26.8	97.0	237.6	0.6	0.1	20.3	7.7	17.8	1.1	0.4	0.5	17.2	318.8	0.0	249.6	12.7	0.3	3.2	174.3	11.5	0.1	276.6	437.6	15.9	0.1	139.7	15.3	0.0	1814.6	675.2	8.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	148.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	2.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.9	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.2	1.0	40.6	0.0	0.0	2.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.2	0.4	21.6	15.2	47.3	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.0	2.3	353.9	0.1	0.1	0.2	292.4	0.1	0.1	27.9	0.1	0.1	1.2	0.2	27.6	0.0	0.1	0.0	0.6	0.1	0.0	0.6	0.1	0.5	0.1	0.1	0.3	0.0	0.0	0.6	0.0	148.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.8	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.3	1.8	26.7	0.0	0.0	0.0	4.4	67.8	0.0	0.0	0.0	3.6	2.8	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10791.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.1	0.0	0.0	6.2	0.0	0.5	0.0